Forte Biosciences, Inc. (FBRX)
20.77
+0.70
(+3.49%)
USD |
NASDAQ |
May 20, 09:48
Forte Biosciences Shareholders Equity (Quarterly) : 42.10M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 67.22M |
| Total Liabilities (Quarterly) | 25.12M |
| Current Ratio | 2.753 |